![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, March 29, 2014 2:34:56 PM
If they have any capital funding for trials that they're working through something like a Cassel Salpeter, I don't see how we would know that.
But they did retain them, and I'm sure something is being worked regarding trial funding or else all this would be for naught, but again no way to know for certain based on public info.
My guess is that whoever holds these warrants, if exercised, would certainly work to keep the price up so they can take some profits before any more big news, good or bad... Maybe a reason why we're seeing a slightly different trading pattern now.
As for trial funding, I remember a press release about a 2 Million USD term sheet from Vitalmex in 2012, but that then seemed to vanish. I could be wrong as I know the Angel was done in Mexico, with them? Maybe someone can add, shed some light here for me?
Oh, and by the way, got a response yesterday from clinicaltrials asking me to check with Bioheart on why Mirror wasn't registered, so guess I will do that...
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM